SGS Belgium

Running trials

• Recruiting

  A Two-part study to learn the amount of polymyxin E1 in the body over time formed after a single inhaled dose of colistimethate sodium (CMS) in healthy adults (Part 1) and after single inhaled and vein-infused doses of CMS in adults with non‑cystic fibrosis bronchiectasis (NCFB) (Part 2)

  2025-524324-22-00· Phase 1· Source

• Recruiting

  A clinical trial of MK-1824 in healthy participants (MK-1824-002)

  2026-527518-22-00· Phase 1· Source

• Recruiting

  A trial in healthy participants to find out how long JNJ-101556143 stays in and acts on the body when administered as different formulations and under different food conditions

  2026-526263-38-00· Phase 1· Source

• Recruiting

  A Phase 1 first-in-human study to evaluate SAR447754 in healthy adult participants and in adult participants with moderate-to-severe atopic dermatitis.

  2025-523826-41-00· Phase 1· Source

• Active, not recruiting

  Phase 1, Randomized, Double-blind, Placebo-Controlled, First-in-Human Single Ascending Dose Study in Healthy Participants to Assess the Safety, Tolerability, and Pharmacokinetics of JNJ-95597528 and a Proof of Mechanism Study in Participants with Mild to Moderate Asthma

  2024-517644-62-00· Phase 1· Source

• Recruiting

  A placebo-controlled, single-blind, phase I study in healthy volunteers and patients with Rheumatoid Arthritis with ABO21009

  2024-517547-31-00· Phase 1· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atopic dermatitis (eczema)1 recruiting
• Cystic fibrosis1 recruiting
• Heart failure1 recruiting
• Prostate cancer1 recruiting
• Rheumatoid arthritis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Randomised, Placebo‑Controlled Trial to Assess Effect of IMU‑838 on QT/QTc

  2026-526859-54-00· Phase 1· Source

• Completed

  A Phase 1, drug-drug interaction trial of IMU-838 with oral contraceptives in women

  2026-525208-90-00· Phase 1· Source

• Completed

  A study to evaluate how well single and multiple doses of O3R-5671-PRO are tolerated in healthy adult subjects

  2025-522571-28-00· Phase 1· Source

• Completed

  A Multiple Ascending Dose Study With AGMB-129 in Healthy Participants

  NCT07118878· Phase 1· Source

• Completed

  A study to investigate safety, tolerability, pharmacokinetics and efficacy of REM0045392 compared with placebo in healthy participants

  2025-520454-11-00· Phase 1· Source

• Completed

  A clinical study of MK-2420 in healthy people (MK-2420-002)

  2024-516548-25-00· Phase 1· Source

• Completed

  Not applicable

  2024-518150-17-00· Phase 1· Source

• Completed

  Evaluation of the CHF 5993 concentration in blood, after inhalation with two different devices, (NEXThaler® versus pMDI), with and without Aerochamber spacer device, in healthy volunteers.

  2024-512792-13-00· Phase 1· Source

• Completed

  A clinical study of MK-3214 in healthy people (MK-3214-001)

  2024-516016-17-00· Phase 1· Source

• Completed

  A Study to Test Whether BI 456906 (Survodutide) Influences the Amount of Bupropion, Caffeine and Midazolam in the Blood in People With Overweight or Obesity

  NCT06564441· Phase 1· Source

• Completed

  Comparison of the study drug CHF 1535 formulated with two different propellants to learn about drug levels in blood and safety after inhalation, with and without the use of the AeroChamber Plus® spacer, in healthy volunteers.

  2024-514247-28-00· Phase 1· Source

• Completed

  A study to test how well different doses of BI 3804379 are tolerated by healthy people and patients with MASH

  2024-513549-36-01· Phase 1· Source

• Completed

  Comparison of the study drug CHF 1535 formulated with two different propellants to learn about drug levels in blood and safety after inhalation, with and without the use of the Aerochamber Plus® spacer, in healthy volunteers.

  2023-510171-59-00· Phase 1· Source

• Completed

  MK-7091 Formulations Study in Healthy Adult Participants

  2023-510402-40-00· Phase 1· Source

• Completed

  A Multiple-Ascending-Dose Study of MK-1708 in Healthy Participants

  2024-511405-27-00· Phase 1· Source

• Completed

  Safety and tolerability of single and multiple ascending doses of lunsekimig (SAR443765) in healthy participants

  2023-509316-28-00· Phase 1· Source

• Completed

  MK-7480 Multiple Ascending Dose Study in Healthy Participants

  2023-508982-34-00· Phase 1· Source

• Completed

  A phase I study to evaluate an investigational medicinal product for the treatment of asthma, in healthy adult participants.

  2023-504326-19-00· Phase 1· Source

• Completed

  "Safety, efficacy, immunogenicity study of GSK Biologicals’ HBV viral vector and adjuvanted proteins vaccine (GSK3528869A) in adult patients with chronic Hepatitis B infection. "

  NCT03866187· Phase 1/2· Source